CYRX (CryoPort) EBIT: $-32.8 Mil (TTM As of Mar. 2026)


CYRX CryoPort Inc CYRX
72 GF Score
Price $15.53
GF Value $10.97
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is CryoPort EBIT?

CryoPort CYRX +5.11% 72 EBIT is $-32.8 Mil as of Mar. 2026. GuruFocus rates CYRX with a GF Score™ of 72/100 and a GF Value™ of $10.97 (Significantly Overvalued). The stock has 9 warning signs investors should review.

CryoPort's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $-8.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $-32.8 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. CryoPort's annualized ROC % for the quarter that ended in Mar. 2026 was -7.81%. CryoPort's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -22.11%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. CryoPort's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -5.02%.


CryoPort  (NAS:CYRX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

CryoPort's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-38.456 * ( 1 - 0% )/( (482.925 + 502.004)/ 2 )
=-38.456/492.4645
=-7.81 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=764.989 - 24.908 - ( 411.208 - max(0, 219.018 - 476.174+411.208))
=482.925

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=763.609 - 15.937 - ( 403.634 - max(0, 224.867 - 470.535+403.634))
=502.004

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

CryoPort's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-35.568/( ( (125.168 + max(35.76, 0)) + (129.104 + max(31.643, 0)) )/ 2 )
=-35.568/( ( 160.928 + 160.747 )/ 2 )
=-35.568/160.8375
=-22.11 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(33.359 + 23.188 + 8.419) - (24.908 + 0.943 + 3.355)
=35.76

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.004 + 21.75 + 6.147) - (15.937 + 2.314 + 17.007)
=31.643

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

CryoPort's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=-32.78/653.626
=-5.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CryoPort EBIT Related Terms


CryoPort EBIT Historical Data

* Premium members only.

The historical data trend for CryoPort's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CryoPort EBIT Chart

CryoPort Annual Data
Trend Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -269.15 -28.95 -78.63 -100.37 -29.81

CryoPort Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.92 -11.12 -6.01 -6.76 -8.89

CYRX vs RLGT, FWRD, PAL: EBIT Comparison

For the Integrated Freight & Logistics subindustry, CryoPort's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CryoPort EV-to-EBIT vs Transportation Industry

For the Transportation industry and Industrials sector, CryoPort's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where CryoPort's EV-to-EBIT falls into.


CYRX
72GF Score
CryoPort Inc CYRX
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CryoPort EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-32.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-32.8 Mil mean?
CryoPort (CYRX) has a EBIT of $-32.8 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CryoPort.
Is CryoPort's EBIT too high?
CryoPort's current EBIT is $-32.8 Mil. Overall, CryoPort has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CryoPort's EBIT compare to RLGT and FWRD?
CryoPort's EBIT of $-32.8 Mil can be compared against companies in the Transportation industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Transportation company?
A good EBIT depends on the Transportation industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on CryoPort. CryoPort's current EBIT is $-32.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CryoPort stock overvalued right now?
Based on GuruFocus' analysis, CryoPort (CYRX) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.97, compared to a current price of $15.53 — trading 41.5% above its estimated fair value. The current EBIT is $-32.8 Mil. CryoPort's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For CryoPort (CYRX), the current EBIT is $-32.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CryoPort (CYRX) Overvalued in 2026?

Based on GuruFocus' analysis, CryoPort stock appears to be overvalued. The current stock price of $15.53 is trading 41.5% above its estimated GF Value™ of $10.97. GuruFocus considers CryoPort to be Significantly Overvalued.

Key valuation signals for CYRX:

  • EBIT: $-32.8 Mil
  • GF Value™: $10.97 vs. price of $15.53 (41.5% above fair value)
  • GF Score™: 72/100 with 9 warning signs

No single metric tells the full story. See the CYRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CryoPort Business Description

Other Exchanges CKX:Germany
Address 112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
72GF Score

Get the complete analysis for CYRX

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.53
Price
$10.97
GF Value